217 related articles for article (PubMed ID: 38319971)
1. Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.
Li SY; Hammarlund JA; Wu G; Lian JW; Howell SJ; Clarke RB; Adamson AD; Gonçalves CF; Hogenesch JB; Anafi RC; Meng QJ
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2311854121. PubMed ID: 38319971
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific circadian clock dysregulation modulates breast cancer biology, invasiveness, and prognosis.
Hammarlund JA; Li SY; Wu G; Lian JW; Howell SJ; Clarke R; Adamson A; Gonçalves CF; Hogenesch JB; Meng QJ; Anafi RC
bioRxiv; 2023 May; ():. PubMed ID: 37293090
[TBL] [Abstract][Full Text] [Related]
3. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks.
De A; Beligala DH; Sharma VP; Burgos CA; Lee AM; Geusz ME
Clin Exp Metastasis; 2020 Oct; 37(5):617-635. PubMed ID: 32816185
[TBL] [Abstract][Full Text] [Related]
5. Circadian clocks and breast cancer.
Blakeman V; Williams JL; Meng QJ; Streuli CH
Breast Cancer Res; 2016 Sep; 18(1):89. PubMed ID: 27590298
[TBL] [Abstract][Full Text] [Related]
6. The circadian clock is disrupted in pancreatic cancer.
Schwartz PB; Nukaya M; Berres ME; Rubinstein CD; Wu G; Hogenesch JB; Bradfield CA; Ronnekleiv-Kelly SM
PLoS Genet; 2023 Jun; 19(6):e1010770. PubMed ID: 37262074
[TBL] [Abstract][Full Text] [Related]
7. Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy.
Lee Y; Tanggono AS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430659
[TBL] [Abstract][Full Text] [Related]
8. Identification of circadian-related gene expression profiles in entrained breast cancer cell lines.
Gutiérrez-Monreal MA; Treviño V; Moreno-Cuevas JE; Scott SP
Chronobiol Int; 2016; 33(4):392-405. PubMed ID: 27010605
[TBL] [Abstract][Full Text] [Related]
9. Circadian oscillations persist in low malignancy breast cancer cells.
Lellupitiyage Don SS; Lin HH; Furtado JJ; Qraitem M; Taylor SR; Farkas ME
Cell Cycle; 2019 Oct; 18(19):2447-2453. PubMed ID: 31357909
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the circadian clock drives
Chun SK; Fortin BM; Fellows RC; Habowski AN; Verlande A; Song WA; Mahieu AL; Lefebvre AEYT; Sterrenberg JN; Velez LM; Digman MA; Edwards RA; Pannunzio NR; Seldin MM; Waterman ML; Masri S
Sci Adv; 2022 Aug; 8(32):eabo2389. PubMed ID: 35947664
[TBL] [Abstract][Full Text] [Related]
11. Circadian disruption and breast cancer: an epigenetic link?
Kochan DZ; Kovalchuk O
Oncotarget; 2015 Jul; 6(19):16866-82. PubMed ID: 26220712
[TBL] [Abstract][Full Text] [Related]
12. Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.
Rossetti S; Esposito J; Corlazzoli F; Gregorski A; Sacchi N
Cell Cycle; 2012 Jan; 11(2):350-60. PubMed ID: 22193044
[TBL] [Abstract][Full Text] [Related]
13. Real time, in vivo measurement of neuronal and peripheral clocks in
Johnstone PS; Ogueta M; Akay O; Top I; Syed S; Stanewsky R; Top D
Elife; 2022 Oct; 11():. PubMed ID: 36190119
[TBL] [Abstract][Full Text] [Related]
14. Cancer clocks in tumourigenesis: the p53 pathway and beyond.
Stephenson EM; Usselmann LEJ; Tergaonkar V; Virshup DM; Dallmann R
Endocr Relat Cancer; 2021 Apr; 28(4):R95-R110. PubMed ID: 33638942
[TBL] [Abstract][Full Text] [Related]
15. The circadian clock and cancer: links between circadian disruption and disease Pathology.
Fekry B; Eckel-Mahan K
J Biochem; 2022 May; 171(5):477-486. PubMed ID: 35191986
[TBL] [Abstract][Full Text] [Related]
16. Circadian gene variants and breast cancer.
Reszka E; Przybek M; Muurlink O; Pepłonska B
Cancer Lett; 2017 Apr; 390():137-145. PubMed ID: 28109907
[TBL] [Abstract][Full Text] [Related]
17. Modulation of circadian rhythms through estrogen receptor signaling.
Hatcher KM; Royston SE; Mahoney MM
Eur J Neurosci; 2020 Jan; 51(1):217-228. PubMed ID: 30270552
[TBL] [Abstract][Full Text] [Related]
18. CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients.
Liu Y; Guo S; Sun Y; Zhang C; Gan J; Ning S; Wang J
J Transl Med; 2023 Mar; 21(1):185. PubMed ID: 36895015
[TBL] [Abstract][Full Text] [Related]
19. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
Ye Y; Xiang Y; Ozguc FM; Kim Y; Liu CJ; Park PK; Hu Q; Diao L; Lou Y; Lin C; Guo AY; Zhou B; Wang L; Chen Z; Takahashi JS; Mills GB; Yoo SH; Han L
Cell Syst; 2018 Mar; 6(3):314-328.e2. PubMed ID: 29525205
[TBL] [Abstract][Full Text] [Related]
20. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
